Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62,912,484
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
58,037,496
-
Shares change
-
-1,966,326
-
Total reported value, excl. options
-
$270,452,676
-
Value change
-
-$10,612,704
-
Put/Call ratio
-
23%
-
Number of buys
-
58
-
Number of sells
-
-61
-
Price
-
$4.66
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q3 2023
147 filings reported holding MGNX - MACROGENICS INC - COM as of Q3 2023.
MACROGENICS INC - COM (MGNX) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,037,496 shares
of 62,912,484 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9,803,313 shares), BlackRock Inc. (6,036,030 shares), T. Rowe Price Investment Management, Inc. (5,491,952 shares), ARMISTICE CAPITAL, LLC (4,712,000 shares), VANGUARD GROUP INC (4,414,924 shares), MILLENNIUM MANAGEMENT LLC (2,038,888 shares), Frazier Life Sciences Management, L.P. (1,803,204 shares), WASATCH ADVISORS LP (1,409,534 shares), ACADIAN ASSET MANAGEMENT LLC (1,371,396 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,320,000 shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.